Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...
Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...
Investing.com - Pyxis Oncology Inc. (NASDAQ:PYXS) shares declined after RBC Capital lowered its price target to $5.00 from $8.00 while maintaining an Outperform rating. The adjustment follows Pyxis ...
BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced preliminary data from ongoing Phase 1 clinical studies of its antibody-drug conjugate micvotabart pelidotin (MICVO) in patients with ...
For James Westlake, a recent Naked Wines campaign required a camera able to produce excellent images in a fast, lightweight, handheld setup, and the PYXIS 12K fit the bill. James Westlake is a UK ...
Maroussi, Greece – November 21, 2025 – Pyxis Tankers Inc. (the “Company”) (NASDAQ Cap Mkts: PXS), (the “Company”, “we”, “our”, “us” or ...
Maroussi, Greece, November 19, 2025 - Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international shipping company with a focus on the seaborne transportation of refined petroleum products and dry ...
Most camper van conversions we cover here on autoevolution are based on brand-new vans. However, a slightly older chassis works just as well and can help save you a decent amount of money. Today, I'm ...
Overview: Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics for the treatment of solid tumors, with a market cap of $220.78 million. Operations: The company generates ...
Fintel reports that on November 4, 2025, Guggenheim maintained coverage of Pyxis Oncology (NasdaqGS:PYXS) with a Buy recommendation. Analyst Price Forecast Suggests 60.63% Upside As of October 30, ...
HOUSTON, Sept. 19, 2025 /PRNewswire/ -- Pyxis Advisory Group, a diversified advisory firm serving the global industrial sector, has acquired Catule Consulting, effective September 1, 2025. As part of ...
Fintel reports that on September 4, 2025, Guggenheim initiated coverage of Pyxis Oncology (NasdaqGS:PYXS) with a Buy recommendation. Analyst Price Forecast Suggests 290.37% Upside As of September 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results